best weight loss medication,Eli Lilly Foundayo pill,Eli Lilly stock analysis,Foundayo prescription data,GLP-1 oral drugs,LillyDirect weight loss,next generation weight loss pills,non-injectable weight loss drugs,Novo Nordisk vs Eli Lilly,obesity treatment news,pharmaceutical industry news,Wegovy oral pill,weight loss drug market trends,weight loss pill 2026

Health, World

Eli Lilly vs. Novo Nordisk: The High-Stakes Battle for the Weight-Loss Pill Market

NEW YORK – The race to dominate the global weight-loss industry has moved from injections to oral medication, as Eli Lilly’s new pill, Foundayo, faces its first major test against market leader Novo Nordisk. Recent